Ex Parte Travelute et al - Page 9

                Appeal 2006-2352                                                                                 
                Application 10/065,436                                                                           

                § 103.  In re Spada, 911 F.2d 705, 708, 15 USPQ2d 1655, 1658; In re                              
                Fitzgerald, 619 F.2d 67, 70,  205 USPQ 594, 596 (CCPA 1980); In re Best,                         
                562 F.2d 1252, 1254-55, 195 USPQ 430, 433 (CCPA 1977).                                           
                       Arguments not made in the Briefs are considered to be waived.  See                        
                37 C.F.R. § 41.37(c)(vii) (2006).                                                                

                                                  ANALYSIS                                                       
                       As we noted above, representative claim 2 employs “consisting                             
                essentially of” transistional phrasing.  Our review of the record reveals,                       
                however, that Appellants have not specifically pointed to any persuasive                         
                evidence establishing that the use of sulfonate pore-formers with or without                     
                the retention of some of the pore-former with the filaments, as taught by                        
                Shiozaki, would detrimentally affect the basic and novel characteristics of                      
                Appellants’ invention.  Consequently, Appellants’ unsupported arguments in                       
                the Brief fall significantly short of establishing that the “consisting                          
                essentially of” transistional phrase of representative claim 2 requires                          
                exclusion of a hollow PET-containing filament prepared using sulfonate                           
                pore-formers as described by Shiozaki.                                                           
                       Appellants refer to the four corners of the claim and MPEP                                
                § 2163(II)(A)(1) in the Brief (Br. 5), however, our review of representative                     
                claim 2 reveals no exclusion of the use of the sulfonate pore-formers, as                        
                disclosed by Shiozaki, in manufacturing the claimed filament.  To the extent                     
                Appellants’ reference to the four corners of the claim and the cited Section                     
                of the MPEP in the Brief refers to the claim term “polyester,” Appellants                        
                have not articulated in their arguments how that representative claim term                       
                would exclude the use of sulfonate pore-formers in producing the claimed                         

                                                       9                                                         

Page:  Previous  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  Next

Last modified: September 9, 2013